Efficacy of the ATP Switch Automatic Programming in Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D) Implanted Patients

MicroPort CRM1,254 enrolled

Overview

Primary objective is to assess the efficacy of the new ATP Autoswitch function in simple, dual or triple chamber ICD.

The efficacy rate of the ATP Auto-switch function, defined as the % of VT episodes successfully reduced, will be compared with 85%.

Study Type

OBSERVATIONAL

Enrollment

1,254

Conditions

Ventricular Arrythmias

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * The patient has been implanted (primo implantation or replacement) with an ICD model PARADYM VR 8250, DR 8550, CRT 8750, CRT 8770 models or any similar or higher range device * ATP Auto-switch function is programmed ON Exclusion Criteria: * Presence of a contra-indication to the ICD therapy * Life expectancy less than 12 months

Locations (1)

CHU Brest

Brest, France

Outcomes

Primary Outcomes

Ventricular Tachyarrhythmia episode

% of VT episode successfully reduced by the ATP Auto-switch

Time frame: 2 years

Secondary Outcomes

Arrhythmia incidence

DEvice based data

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.